[Edaily Reporter Kwon Oh Seok ] CARRY(313760)announced on the 27th that it is withdrawing its plan for a rights offering worth approximately 10 billion won. The company explained, "After comprehensively reviewing our fundraising plans and various conditions, we have decided to withdraw the previous decision to conduct a third-party allocation rights offering." The company had originally decided to conduct the capital increase in August of last year and had planned to proceed with a third-party allocation to the Monarch No. 1 Consortium.
Disclosure Plus
CARRY Withdraws Plan for 10 Billion Won Rights Offering
Economy
Corporation
IT·Science
Economy
Samsung DX Union Holds Long-Term Protest in Front of Jay Y. Lee’s Residence… “Close the Compensation Gap”
“Donghaeng,” a labor union composed primarily of employees from SamsungElectronics’ Device Experience (DX) Division, is holding a rally in front of Jay Y. Lee’s residence to demand the elimination of …
Corporation
SK BIOPHARMACEUTICALS’s $400 Million Gamble… A Bigger Picture Than ‘A Second Excofry’ [Invest Bio]
SK BIOPHARMACEUTICALS(326030)is attributing significance beyond that of a mere follow-up pipeline to Opakalim (BHV-7000), a new epilepsy drug candidate it acquired from the U.S.-based Biohaven. It is …
IT·Science
GC Wellbeing and JW Pharmaceutical Rally [K-bio Pulse]
South Korea’s pharmaceutical and biotech sector experienced significant volatility on August 13, driven by growth themes in obesity/medical aesthetics, hair loss, and immuno-oncology. #GCWellbeing sur…